CD69 and leukemia: We confirmed that the significant decrease of leukaemia counts was mainly driven by CAR T cell activation where patient CAR T cells enhanced their surface expression of CD69 in matched leukaemia chips but not in control chips (Fig. 6c and Extended Data Fig. 8d).